SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001015402-05-003407
Filing Date
2005-07-13
Accepted
2005-07-13 16:54:22
Documents
2
Period of Report
2005-07-13
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMEX EXTENDS COMPLIANCE PLAN 07-13-05 extendedcomplainceplan071305.htm 8-K 27979
2 AMEX EXTENDS COMPLIANCE PLAN PERIOD amexextends.htm EX-99 15368
  Complete submission text file 0001015402-05-003407.txt   45124
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 05952769
SIC: 2834 Pharmaceutical Preparations